Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial
Crossref DOI link: https://doi.org/10.1007/s12325-018-0862-2
Published Online: 2019-01-03
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xiong, Jie
Zhao, Guifang
Yang, Shengli
Chen, Jing
Text and Data Mining valid from 2019-01-03
Article History
Received: 6 November 2018
First Online: 3 January 2019